• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Body Composition Changes Over the Menopausal Transition in Women With and Without Human Immunodeficiency Virus.绝经过渡期女性中有无人类免疫缺陷病毒感染者的身体成分变化。
Clin Infect Dis. 2023 Jul 26;77(2):265-271. doi: 10.1093/cid/ciad165.
2
Switch to Integrase Strand Transfer Inhibitors during the Menopausal Transition is Associated with Accelerated Body Composition Change in Women with HIV.在绝经过渡期间改用整合酶链转移抑制剂与感染艾滋病毒女性的身体成分加速变化有关。
Clin Infect Dis. 2024 Nov 4. doi: 10.1093/cid/ciae540.
3
Association of Androgen Hormones, Sex Hormone-Binding Globulin, and the Menopausal Transition With Incident Diabetes Mellitus in Women With and Without HIV.雄激素、性激素结合球蛋白与绝经过渡在有和没有艾滋病毒的女性中与新发糖尿病的关联。
J Acquir Immune Defic Syndr. 2024 Apr 15;95(5):486-493. doi: 10.1097/QAI.0000000000003380.
4
Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution.用于围绝经期和绝经后女性的雌激素和孕激素激素替代疗法:体重与体脂分布
Cochrane Database Syst Rev. 2000(2):CD001018. doi: 10.1002/14651858.CD001018.
5
The mental health challenges, especially suicidality, experienced by women during perimenopause and menopause: A qualitative study.围绝经期和绝经期间女性所面临的心理健康挑战,尤其是自杀倾向:一项定性研究。
Womens Health (Lond). 2025 Jan-Dec;21:17455057251338941. doi: 10.1177/17455057251338941. Epub 2025 Jul 8.
6
Women's experience of menopause: a systematic review of qualitative evidence.女性更年期经历:定性证据的系统评价
JBI Database System Rev Implement Rep. 2015 Sep 16;13(8):250-337. doi: 10.11124/jbisrir-2015-1948.
7
Obesity is associated with lower bacterial vaginosis prevalence in menopausal but not pre-menopausal women in a retrospective analysis of the Women's Interagency HIV Study.在对妇女艾滋病研究机构间研究的回顾性分析中,肥胖与绝经后妇女细菌性阴道病的患病率降低相关,但与绝经前妇女无关。
PLoS One. 2021 Mar 8;16(3):e0248136. doi: 10.1371/journal.pone.0248136. eCollection 2021.
8
Factors associated with worse cerebrovascular function in aging women with and at risk for HIV.与伴有和有 HIV 风险的老年女性脑血管功能恶化相关的因素。
AIDS. 2021 Feb 2;35(2):257-266. doi: 10.1097/QAD.0000000000002755.
9
Dehydroepiandrosterone for women in the peri- or postmenopausal phase.绝经前后阶段女性使用脱氢表雄酮。
Cochrane Database Syst Rev. 2015 Jan 22;1(1):CD011066. doi: 10.1002/14651858.CD011066.pub2.
10
Does cognitive intra-individual variability predict change in everyday functioning performance in women with and without HIV in the Women's Interagency HIV Study?在女性机构间HIV研究中,认知个体内变异性能否预测有HIV和无HIV女性日常功能表现的变化?
Appl Neuropsychol Adult. 2024 Dec 24:1-11. doi: 10.1080/23279095.2024.2444573.

引用本文的文献

1
Weight loss with real-world doravirine use in the OPERA cohort: a US-based cohort study.OPERA队列中实际使用多拉韦林的体重减轻情况:一项基于美国的队列研究。
AIDS Res Ther. 2025 Jun 21;22(1):64. doi: 10.1186/s12981-025-00761-5.
2
Switch to Integrase Strand Transfer Inhibitors during the Menopausal Transition is Associated with Accelerated Body Composition Change in Women with HIV.在绝经过渡期间改用整合酶链转移抑制剂与感染艾滋病毒女性的身体成分加速变化有关。
Clin Infect Dis. 2024 Nov 4. doi: 10.1093/cid/ciae540.

本文引用的文献

1
Dissecting drivers of immune activation in chronic HIV-1 infection.解析慢性 HIV-1 感染中免疫激活的驱动因素。
EBioMedicine. 2022 Sep;83:104182. doi: 10.1016/j.ebiom.2022.104182. Epub 2022 Jul 26.
2
The Effect of Menopausal Status, Age, and Human Immunodeficiency Virus (HIV) on Non-AIDS Comorbidity Burden Among US Women.绝经状态、年龄和人类免疫缺陷病毒(HIV)对美国女性非艾滋病合并症负担的影响。
Clin Infect Dis. 2023 Feb 8;76(3):e755-e758. doi: 10.1093/cid/ciac465.
3
Menopause Is Associated With Immune Activation in Women With HIV.绝经与 HIV 感染者的免疫激活有关。
J Infect Dis. 2022 Jan 18;225(2):295-305. doi: 10.1093/infdis/jiab341.
4
Impact of Integrase inhibitors and tenofovir alafenamide on weight gain in people with HIV.整合酶抑制剂和替诺福韦艾拉酚胺对 HIV 感染者体重增加的影响。
Curr Opin HIV AIDS. 2021 May 1;16(3):148-151. doi: 10.1097/COH.0000000000000680.
5
Characteristics of the MACS/WIHS Combined Cohort Study: Opportunities for Research on Aging With HIV in the Longest US Observational Study of HIV.MACS/WIHS 联合队列研究的特点:在最长的美国 HIV 观察研究中,研究 HIV 伴随衰老的机会。
Am J Epidemiol. 2021 Aug 1;190(8):1457-1475. doi: 10.1093/aje/kwab050.
6
CYP2B6 Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz.CYP2B6 基因型与多替拉韦和依非韦伦所致体重增加的差异。
Clin Infect Dis. 2021 Dec 6;73(11):e3902-e3909. doi: 10.1093/cid/ciaa1073.
7
Correlates and Timing of Reproductive Aging Transitions in a Global Cohort of Midlife Women With Human Immunodeficiency Virus: Insights From the REPRIEVE Trial.全球队列中年感染人类免疫缺陷病毒女性生殖衰老转变的相关性和时间:来自 REPRIEVE 试验的见解。
J Infect Dis. 2020 Jul 9;222(Suppl 1):S20-S30. doi: 10.1093/infdis/jiaa214.
8
Antimullerian Hormone and Impending Menopause in Late Reproductive Age: The Study of Women's Health Across the Nation.抗缪勒管激素与晚生育期临近绝经期:妇女健康全国性研究。
J Clin Endocrinol Metab. 2020 Apr 1;105(4):e1862-71. doi: 10.1210/clinem/dgz283.
9
Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials.抗逆转录病毒治疗起始后体重增加:随机对照临床试验中的危险因素。
Clin Infect Dis. 2020 Sep 12;71(6):1379-1389. doi: 10.1093/cid/ciz999.
10
Changes in body composition and weight during the menopause transition.绝经过渡期的身体成分和体重变化。
JCI Insight. 2019 Mar 7;4(5). doi: 10.1172/jci.insight.124865.

绝经过渡期女性中有无人类免疫缺陷病毒感染者的身体成分变化。

Body Composition Changes Over the Menopausal Transition in Women With and Without Human Immunodeficiency Virus.

机构信息

Department of Medicine, University of California, San Francisco, USA.

Department of Epidemiology and Biostatistics, University of California, San Francisco, USA.

出版信息

Clin Infect Dis. 2023 Jul 26;77(2):265-271. doi: 10.1093/cid/ciad165.

DOI:10.1093/cid/ciad165
PMID:36974507
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10371311/
Abstract

BACKGROUND

Women are at risk for weight gain during the transition to menopause, but few have examined the contribution of menopause to weight gain in women with human immunodeficiency virus (WWH).

METHODS

From 2000 to 2013, participants (621 WWH; 218 without HIV [WWOH]) from the Women's Interagency HIV Study were categorized by menopausal phase using serial measures of anti-Müllerian hormone (AMH). Multivariable linear mixed models examined the association of menopausal phase with body mass index (BMI) and waist circumference (WC) trajectory, stratified by HIV status.

RESULTS

In models controlled for chronologic age, the estimated effects (95% confidence interval) of menopausal phase on annual rate of BMI change across early perimenopause, late perimenopause, and menopause, respectively, compared to premenopause were -0.55% (-.80 to -.30), -0.29% (-.61 to .03), and -0.67% (-1.12 to -.20) in WWH, whereas estimated effects were 0.43% (-.01 to .87) and 0.15% (-.42 to .71) across early and late perimenopause, respectively, and -0.40% (-1.24 to .45) across menopause in WWOH. The estimated effects on rate of WC change were negative across early perimenopause (-0.21% [-.44 to .03]) and menopause (-0.12% [-.5 to .26]) and positive across late perimenopause (0.18% [-.10 to .45]) in WWH, and positive across all 3 menopausal phases in WWOH, but these effects were not statistically significant.

CONCLUSIONS

In WWH, the menopausal transition was associated with BMI and WC trajectories that were mostly in a negative direction and opposite from WWOH after adjusting for age, suggesting that HIV blunts weight gain during the menopausal transition.

摘要

背景

女性在绝经过渡期间有体重增加的风险,但很少有研究检查绝经对感染人类免疫缺陷病毒(HIV)的女性(WWH)体重增加的贡献。

方法

2000 年至 2013 年,来自妇女艾滋病病毒研究机构间小组的参与者(621 名 WWH;218 名无 HIV [WWOH])根据抗苗勒氏管激素(AMH)的连续测量结果分为绝经阶段。多变量线性混合模型检查了绝经阶段与体重指数(BMI)和腰围(WC)轨迹的关联,按 HIV 状态分层。

结果

在控制年龄的模型中,与绝经前相比,绝经过渡期、晚期绝经和绝经后分别估计的绝经阶段对 BMI 年变化率的影响(95%置信区间)在 WWH 中分别为-0.55%(-0.80 至-0.30)、-0.29%(-0.61 至 0.03)和-0.67%(-1.12 至-0.20),而在 WWOH 中,估计的影响分别为 0.43%(-0.01 至 0.87)和 0.15%(-0.42 至 0.71),在绝经期间为 0.40%(-1.24 至 0.45)。在 WWH 中,在绝经早期(-0.21%[-0.44 至 0.03])和绝经后期(-0.12%[-0.5 至 0.26])WC 变化率的估计影响为负,而在绝经后期(0.18%[-0.10 至 0.45])为正,而在 WWOH 中,所有 3 个绝经阶段均为正,但这些影响无统计学意义。

结论

在 WWH 中,绝经过渡与 BMI 和 WC 轨迹相关,这些轨迹在调整年龄后大多为负向,与 WWOH 相反,这表明 HIV 减轻了绝经过渡期间的体重增加。